UOC
CLB icon

UBS O'Connor’s Core Laboratories CLB Stock Holding History

UBS O'Connor’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$1.4M – 329
2019
Q3 		$1.4M Buy
+30,000
New +$1.39M 0.04% 190
2019
Q1 		– Sell
-50,000
Closed -$2.98M – 240
2018
Q4 		$2.98M Buy
+50,000
New +$4.31M 0.11% 110
2016
Q4 		– Sell
-34,000
Closed -$3.82M – 408
2016
Q3 		$3.82M Sell
34,000
-54,351
-62% -$6.26M 0.06% 247
2016
Q2 		$10.9M Buy
+88,351
New +$10.7M 0.24% 111
2016
Q1 		– Sell
-18,200
Closed -$1.98M – 457
2015
Q4 		$1.98M Sell
18,200
-15,200
-46% -$1.74M 0.02% 319
2015
Q3 		$3.33M Sell
33,400
-128,740
-79% -$14M 0.03% 323
2015
Q2 		$18.5M Buy
+162,140
New +$19.7M 0.15% 168

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

UBS O'Connor's CLB Position: Q4 2019 in Review

UBS O'Connor sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 30,000 shares — an estimated $1.4M sold.

UBS O'Connor first reported a position in CLB in Q2 2015 and held it in 7 quarters. The position peaked at $18.5M in Q2 2015. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • UBS O'Connor reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • UBS O'Connor sold 30,000 Core Laboratories shares in Q4 2019, an estimated $1.4M.
  • UBS O'Connor first reported a position in Core Laboratories in Q2 2015 and held it in 7 quarters.
  • UBS O'Connor's Core Laboratories position peaked at $18.5M in Q2 2015.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on UBS O'Connor's 13F filing for Q4 2019, filed 14 Feb 2020.